Longevity fund companies target breakthrough antiaging
23 year old Laura Deming started the Longevity Fund which just closed its second fund with $22 million. The first fund was for $4 million. Longevity fund companies target breakthrough antiaging technology including addressing senescent cells, new genome editing, mTorc pathways and more. The goal of the Longevity fund is to advance technologies that will …